Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

Comer SD, Sullivan MA, Vosburg SK, et al. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction. 2010;105(4):709-718.

Publication Type:

Journal Article

Authors:

Comer, SD; Sullivan, MA; Vosburg, SK; et, al

Source:

Addiction, Volume 105, Issue 4, p.709-718 (2010)

Cited On:

Key Populations: Identification and Management of HCV in People Who Inject Drugs

Export Citation:

RIS Format

Top